HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Approximately 0.1% of the shares of the company are […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 21,400 shares, a decrease of 14.4% from the August 15th total of 25,000 shares. Currently, 0.1% of the company’s stock are short sold. […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 23,200 shares, a drop of 13.4% from the July 15th total of 26,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]
HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 24,300 shares, a growth of 86.9% from the May 31st total of 13,000 shares. Currently, 0.1% of the company’s shares are short sold. Based […]
HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 24,300 shares, an increase of 86.9% from the May 31st total of 13,000 shares. Based on an average daily trading volume, of 19,500 shares, […]
HCW Biologics (NASDAQ:HCWB – Free Report) and GRI Bio (NASDAQ:GRI – Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Insider & Institutional Ownership 2.4% of HCW Biologics shares […]
HCW Biologics (NASDAQ:HCWB – Get Rating) and 23andMe (NASDAQ:ME – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valuation, earnings, analyst recommendations, institutional ownership and profitability. Earnings and Valuation This table compares HCW Biologics and 23andMe’s […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) CFO Rebecca Byam bought 20,000 shares of HCW Biologics stock in a transaction on Monday, June 5th. The shares were acquired at an average price of $1.67 per share, for a total transaction of $33,400.00. Following the completion of the acquisition, the chief financial officer now owns 480,188 […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) CFO Rebecca Byam acquired 20,000 shares of the company’s stock in a transaction dated Friday, May 26th. The shares were purchased at an average price of $1.66 per share, for a total transaction of $33,200.00. Following the purchase, the chief financial officer now directly owns 460,188 shares of […]